Phase 1/2a study assessing 177Lu-DOTA-RM2 in prostate cancer patients
Latest Information Update: 29 Jan 2025
Price :
$35 *
At a glance
- Drugs LNH 2402 (Primary) ; Gallium 68 RM2
- Indications Prostate cancer
- Focus Adverse reactions; Therapeutic Use
- 29 Jan 2025 New trial record